Skip to main content
Premium Trial:

Request an Annual Quote

Ulrich Krauss

Analytik Jena has appointed current Chief Marketing and Sales Officer Ulrich Krauss as CEO, effective Oct. 1. Krauss will succeed founder Klaus Berka who will stay on to oversee the company's research and development efforts. Krauss has held various international management positions at the Carl Zeiss Group, most recently as the CEO of Carl Zeiss Vision. He has also served on the executive board of Carl Zeiss Meditec for over nine years.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.